Massachusetts Department of Public Health grants WDL to Pharmarama

Pharmarama, a leader in the strategic sourcing of comparator drugs for global clinical trials, today announced that the Massachusetts Department of Public Health has granted the company a Wholesale Distributor’s License (WDL). The license enables Pharmarama to operate its pharmaceutical cold-chain and ambient storage and distribution facility in suburban Boston to provide extensive sourcing and comparator product storage services for its clients.

“This new facility will enable us to introduce our proprietary GlobalBatch™ program, to serve clients in a new paradigm”

“Pharmarama is a one-stop shop for pharmaceutical companies in the United States and throughout the European Union (EU),” said company President Rosemary Bensley. “From our newly licensed facility in Medfield, Mass., we will now serve as a hub for our U.S.-based pharmaceutical clients to efficiently procure U.S. products for their clinical trials. Receipt of this WDL reflects not only our compliance with Good Distribution Practice, but also our commitment to quality underpinned by a robust Quality Management System.

“This new facility will enable us to introduce our proprietary GlobalBatch™ program, to serve clients in a new paradigm,” continued Bensley. “Pharmarama has unique knowledge of the regulatory and data requirements for use of an EU-sourced drug in global adjunctive and comparator studies. In addition, we have the supplier relationships and the infrastructure necessary to procure comparators – often through a single source – for trials conducted anywhere in the world. This skill set enables us to assist clients in developing a highly effective sourcing strategy.”